Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $49.41 USD
Change Today -0.11 / -0.22%
Volume 2.7M
ABT On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
London
Sao Paulo
Frankfurt
As of 8:04 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for abbott laboratories (ABT)

Although debt as a percent of total capital increased at Abbott Laboratories over the last fiscal year to 26.61%, it is still in-line with the Healthcare Equipment and Supplies industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 68.25 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 105.95 days.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Restated
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents6,812.810,802.03,475.04,063.0
Short-Term Investments1,284.54,372.04,623.0397.0
TOTAL CASH AND SHORT TERM INVESTMENTS8,097.415,174.08,098.04,460.0
Accounts Receivable7,683.97,613.03,986.03,586.0
TOTAL RECEIVABLES7,683.97,613.03,986.03,586.0
Inventory3,284.23,793.02,693.02,643.0
Prepaid Expenses1,722.71,637.01,420.01,718.0
Deferred Tax Assets, Current2,700.52,986.02,528.01,705.0
Other Current Assets280.0120.0522.01,149.0
TOTAL CURRENT ASSETS23,768.831,323.019,247.015,261.0
Gross Property Plant and Equipment18,016.618,929.012,870.012,632.0
Accumulated Depreciation-10,142.6-10,866.0-6,965.0-6,697.0
NET PROPERTY PLANT AND EQUIPMENT7,874.08,063.05,905.05,935.0
Goodwill15,705.415,774.09,772.010,067.0
Long-Term Investments976.2459.0206.0330.0
Deferred Tax Assets, Long Term1,962.93,028.02,022.01,550.0
Other Intangibles9,989.68,588.05,735.06,198.0
Other Long-Term Assets----66.01,934.0
TOTAL ASSETS60,276.967,235.042,953.041,275.0
    
LIABILITIES & EQUITY    
Accounts Payable1,721.11,797.01,026.01,064.0
Accrued Expenses6,806.17,816.04,006.03,719.0
Short-Term Borrowings1,667.91,467.02,659.03,937.0
Current Portion of Long-Term Debt/Capital Lease1,706.9924.0514.0500.0
Current Income Taxes Payable514.9655.0175.0270.0
Other Current Liabilities, Total3,063.3621.01,127.01,042.0
TOTAL CURRENT LIABILITIES15,480.213,280.09,507.010,532.0
Long-Term Debt12,039.818,085.03,388.03,408.0
Minority Interest86.392.096.0113.0
Pension & Other Post-Retirement Benefits3,301.04,871.01,818.02,875.0
Deferred Tax Liability Non-Current703.0710.0466.0860.0
Other Non-Current Liabilities4,226.73,476.02,507.01,961.0
TOTAL LIABILITIES35,750.740,422.017,686.019,636.0
Common Stock9,817.111,755.012,048.012,383.0
Retained Earnings20,907.424,151.021,979.022,874.0
Treasury Stock-3,687.5-5,591.0-6,844.0-8,678.0
Comprehensive Income and Other-2,597.2-3,594.0-2,012.0-5,053.0
TOTAL COMMON EQUITY24,439.826,721.025,171.021,526.0
TOTAL EQUITY24,526.126,813.025,267.021,639.0
TOTAL LIABILITIES AND EQUITY60,276.967,235.042,953.041,275.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $49.41 USD -0.11

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $68.21 USD -0.30
AstraZeneca PLC 4,167 GBp -23.00
Danaher Corp $86.80 USD +0.46
Eli Lilly & Co $86.14 USD +1.29
Thermo Fisher Scientific Inc $130.95 USD +0.13
View Industry Companies
 

Industry Analysis

ABT

Industry Average

Valuation ABT Industry Range
Price/Earnings 37.2x
Price/Sales 3.6x
Price/Book 3.4x
Price/Cash Flow 15.4x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.